Romana Kulikova
Neurology with Special Qualifications in Child Neurology · Garwood, NJNPI 1245263441
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.9% of the total across 178 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 12.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,432, 4.0 times the $358 reported in 2019.
Across 178 payments — averaging $20.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$449
- Eisai Inc.$381
- Tris Pharma Inc$319
- Otsuka America Pharmaceutical, Inc.$295
- Teva Pharmaceuticals USA, Inc.$228
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$211
- plus $2K from 28 others
Across 1 payment — averaging $24,382 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- E.r. Squibb & Sons, L.L.C.$24K
What the payments were for
- Travel & lodging$2417%
- Food & beverage$3,37592%
- Education$551%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 6 | $449 |
| Eisai Inc. | 18 | $381 |
| Tris Pharma Inc | 32 | $319 |
| Otsuka America Pharmaceutical, Inc. | 9 | $295 |
| Teva Pharmaceuticals USA, Inc. | 6 | $228 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $211 |
| Neurelis, Inc. | 14 | $191 |
| AbbVie(2 entities) | 11 | $161 |
| Ironshore Pharmaceuticals Inc. | 10 | $154 |
| Biogen | 9 | $141 |
| Corium, LLC | 9 | $125 |
| Novartis | 2 | $114 |
| Acadia Pharmaceuticals Inc | 2 | $88 |
| Vanda Pharmaceuticals Inc. | 3 | $81 |
| Sunovion Pharmaceuticals Inc. | 5 | $80 |
| Alkermes, Inc. | 4 | $61 |
| UCB, Inc. | 4 | $60 |
| NS Pharma, Inc. | 2 | $49 |
| Johnson & Johnson | 2 | $49 |
| Neos Therapeutics, LP | 3 | $42 |
| Lilly USA, LLC | 2 | $41 |
| Aprecia Pharmaceuticals, LLC | 3 | $39 |
| Greenwich Biosciences, Inc. | 2 | $37 |
| Aquestive Therapeutics, Inc. | 3 | $37 |
| Biomarin Pharmaceutical Inc. | 1 | $34 |
| Jazz Pharmaceuticals Inc. | 2 | $29 |
| Lundbeck LLC | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $28 |
| Adlon Therapeutics L.p. | 2 | $28 |
| Integra Lifesciences Corporation | 1 | $27 |
| Novartis Gene Therapies, Inc. (fka Avexis, Inc.) | 1 | $17 |
| Immedica Pharma US, Inc. | 1 | $17 |
| Boehringer Ingelheim | 1 | $16 |
| Vertical Pharmaceuticals, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,671 in reported general payments places this provider in the 85th percentile of 69 neurology with special qualifications in child neurology providers in New Jersey.
See all neurology with special qualifications in child neurology providers in New Jersey →
Other neurology with special qualifications in child neurology in Garwood
- Juliann PaolicchiHackensack$80K
- Trevor DesouzaMorristown$14K
- Rao PasupuletiHamilton$11K
- Aliza AlterLivingston$9K
- Sara RubensteinHackensack$7K
- Carlos LastraNew Brunswick$5K
- Jacqueline RomeroMarlboro$4K
- Sohum TrivediMarlboro$4K
- Rajeshwari MahalinghamNew Brunswick$3K
- Vikram BhiseNew Brunswick$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.